Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-187670
Filing Date
2014-05-07
Accepted
2014-05-07 17:00:55
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d692784d10q.htm 10-Q 478889
2 EX-10.2 d692784dex102.htm EX-10.2 12256
3 EX-31.1 d692784dex311.htm EX-31.1 9273
4 EX-31.2 d692784dex312.htm EX-31.2 9279
5 EX-32.1 d692784dex321.htm EX-32.1 4744
  Complete submission text file 0001193125-14-187670.txt   5182121

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ampe-20140331.xml EX-101.INS 630960
7 XBRL TAXONOMY EXTENSION SCHEMA ampe-20140331.xsd EX-101.SCH 61293
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20140331_cal.xml EX-101.CAL 49689
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20140331_def.xml EX-101.DEF 259911
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20140331_lab.xml EX-101.LAB 447575
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20140331_pre.xml EX-101.PRE 349848
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 14821824
SIC: 2834 Pharmaceutical Preparations